Company record
uniQure biopharma B.V.
- B.V.
Signals
5 on record
- EPO patentsPatent
Patent publication CO2026009231A2 by UNIQURE BIOPHARMA B.V.: Formulaciones de medicamentos virales.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication AU2026254037A1 by UNIQURE BIOPHARMA B.V.: Methods and means for the prevention and/or treatment of hemophilic arthropathy in hemophilia.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication AU2025256404A1 by UNIQURE BIOPHARMA B.V.: NUCLEIC ACID FOR A1AT REGULATION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4816540A1 by uniQure biopharma B.V.: FORMULATIONS FOR VIRAL DRUG PRODUCTS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication US20260297623A1 by uniQure biopharma B.V.: Novel Fragile X Constructs.
EPO patentsRelevance21
Watch · 80% confidence